Back to Trades
Total Value
$857.6K
Filing Date
Mar 2, 2026
1 transaction
Grants
$857.6K
1 transaction
Trade Summary
On Feb 26, 2026, Shanmugam Muthusamy, HEAD OF R&D, COO-NOVITIUM OPS, Director, received $857.6K of ANI PHARMACEUTICALS INC (ANIP) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $77.15. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Role
- HEAD OF R&D, COO-NOVITIUM OPS, Director
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 26, 2026
- Accession Number
- 0001870913-26-000005
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | 11,116 | $77.15 | Grant/Award | $857.6K |
Want live alerts when Shanmugam Muthusamy trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.
- (F2)The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- (F3)The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.